A combination of taskinimod or a pharmaceutically acceptable salt thereof for use as a pharmaceutical and a PD-1 and / or PD-L1 inhibitor.

摘要

The present invention concerns a combination comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and a PD1 and/or PDL1 inhibitor, for use as a medicament. It also concerns a pharmaceutical composition comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and PD1 and/or PDL1 inhibitor.